Literature DB >> 6776034

Killing of the S and Re forms of Salmonella minnesota via the classical pathway of complement activation in guinea-pig and human sera.

F Clas, M Loos.   

Abstract

The S (wildtype) and Re form (heptose-deficient, core-defective mutant) of Salmonella minnesota were killed by treatment with normal guinea-pig serum (GPS). Using C4-deficient GPS and serum containing 0.02 M ethyleneglycol-bis-(beta-aminoethylether)-tetraacetic acid and 0.02 M MgCl2 (EGTA-Mg2+) a reduced killing rate was observed. In normal GPS diluted 1:10 containing 0.02 M EGTA-Mg2+ or in C4-deficient GPS diluted 1:10 no killing occurred, whereas the same serum dilution without EGTA-Mg2+ showed a strong bactericidal effect indicating a dependency upon C4 and Ca2+ ions. Furthermore, in contrast to normal human serum (NHS) no killing occurred in a selective complete C1q-deficient human serum. The bactericidal effect, however, could be restored by addition of highly purified C1q; this is a further indication for a dependency upon the classical pathway of C activation. The C-dependent bactericidal activity was totally abolished when phosphate buffer was used, partially reduced in the presence of veronal-buffered saline (VBS), and not affected by tris-(hydroxymethyl)-aminomethane(Tris) or thioglycollate-buffered system EGTA-Mg2+ alone slightly reduced the growth rate of the bacteria whereas disodium ethylene diaminetetraacetate (EDTA) had a bacteriostatic effect on the S-form. The inhibition of the growth of the Re-form by EDTA was amplified by the addition of serum. Pre-incubation of bacteria with serum for absorption of antibodies did not increase the killing rate of such pre-treated bacteria excluding an antibody-mediated bactericidal reaction. Furthermore, pre-treatment of the bacteria with GPS at 0 degrees reduced the serum sensitivity of both types of bacteria.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6776034      PMCID: PMC1458113     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  17 in total

1.  Interaction of the first (C1), the second (C2) and the fourth (C4) component of complement with different preparations of bacterial lipopolysaccharides and with lipid A.

Authors:  M Loos; D Bitter-Suermann; M Dierich
Journal:  J Immunol       Date:  1974-03       Impact factor: 5.422

2.  Rabbit C1q: purification, functional and structural studies.

Authors:  J E Volanakis; R M Stroud
Journal:  J Immunol Methods       Date:  1972-11       Impact factor: 2.303

3.  Analysis of bypass activation of C3 by endotoxic LPS and loss of this potency.

Authors:  M P Dierich; D Bitter-Suermann; W König; U Hadding; C Galanos; E T Rietschel
Journal:  Immunology       Date:  1973-04       Impact factor: 7.397

4.  Sensitization of complement resistant bacterial strains.

Authors:  B L Reynolds; D Rowley
Journal:  Nature       Date:  1969-03-29       Impact factor: 49.962

5.  Calcium requirements for complement dependent hemolytic reactions.

Authors:  R E Bryant; D E Jenkins
Journal:  J Immunol       Date:  1968-10       Impact factor: 5.422

6.  Studies on the presence and role of tryptophan in pig heart mitochondrial malate dehydrogenase.

Authors:  T L Chan; K A Schellenberg
Journal:  J Biol Chem       Date:  1968-12-10       Impact factor: 5.157

7.  Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS).

Authors:  D C Morrison; L F Kline
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

8.  Sensitivity of rough gram-negative bacteria to the bactericidal action of serum.

Authors:  D Rowley
Journal:  J Bacteriol       Date:  1968-05       Impact factor: 3.490

9.  An alternate complement pathway: C-3 cleaving activity, not due to C4,2a, on endotoxic lipopolysaccharide after treatment with guinea pig serum; relation to properdin.

Authors:  R L Marcus; H S Shin; M M Mayer
Journal:  Proc Natl Acad Sci U S A       Date:  1971-06       Impact factor: 11.205

10.  Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components.

Authors:  H Gewurz; H S Shin; S E Mergenhagen
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

View more
  9 in total

Review 1.  The quest for an intrinsic C3 activating factor in human glomerular disease.

Authors:  J L Roberts; E J Lewis
Journal:  Surv Immunol Res       Date:  1982

2.  Electron microscopic study showing antibody-independent binding of C1q, a subcomponent of the first component of complement, to serum-sensitive salmonellae.

Authors:  F Clas; J R Golecki; M Loos
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

Review 3.  Bactericidal and bacteriolytic activity of serum against gram-negative bacteria.

Authors:  P W Taylor
Journal:  Microbiol Rev       Date:  1983-03

Review 4.  Linkage map of Salmonella typhimurium, Edition VI.

Authors:  K E Sanderson; J R Roth
Journal:  Microbiol Rev       Date:  1983-09

5.  Requirement for an additional serum factor essential for the antibody-independent activation of the classical complement sequence by Gram-negative bacteria.

Authors:  F Clas; M Loos
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

6.  Plasmid-associated resistance of Salmonella typhimurium to complement activated by the classical pathway.

Authors:  J L Vandenbosch; D K Rabert; G W Jones
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

7.  Sensitivity of Capnocytophaga species to bactericidal properties of human serum.

Authors:  M E Wilson; R Burstein; J T Jonak-Urbanczyk; R J Genco
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

8.  Antibody-independent binding of the first component of complement (C1) and its subcomponent C1q to the S and R forms of Salmonella minnesota.

Authors:  F Clas; M Loos
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

9.  Rapid killing of Capnocytophaga canimorsus and Capnocytophaga cynodegmi by human whole blood and serum is mediated via the complement system.

Authors:  Salah Zangenah; Peter Bergman
Journal:  Springerplus       Date:  2015-09-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.